Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Sanara MedTech (SMTI) has shared an announcement.
Zachary B. Fleming stepped down as CEO of Sanara MedTech Inc. on May 10, 2024, and subsequently agreed to a Separation Agreement providing him with a year’s base salary as severance, paid in installments, along with COBRA health coverage for himself and dependents during this period. Additionally, the company will allow 50% of his unvested restricted stock to continue vesting and accelerate a portion of it to cover tax obligations. In return, Fleming has committed to a general release of claims and to adhere to a non-disparagement agreement post-resignation.
For a thorough assessment of SMTI stock, go to TipRanks’ Stock Analysis page.
